 Reversion recent-onset atrial fibrillation rhythm intravenous flecainide Spontaneous reversion rhythm frequent occurrence recent-onset atrial fibrillation AF randomized double-blind study intravenous flecainide mg/kg maximum dose mg placebo treatment recent-onset AF present equal minutes equal hours duration ventricular response equal beats/min Intravenous digoxin micrograms patients groups digoxin trial medication minutes Exclusion criteria hemodynamic instability severe heart failure recent antiarrhythmic therapy hypokalemia pacemaker dependence consecutive patients recent-onset AF study patients underwent continuous electrocardiographic monitoring intensive care coronary care unit Twenty-nine patients digoxin placebo digoxin rhythm equal hour trial medication infusion stable sinus rhythm chi-square odds confidence interval end monitoring period patients flecainide-digoxin group stable sinus rhythm patients placebo-digoxin group chi-square odds confidence interval